Elizabeth E. Evans - May 11, 2021 Form 3 Insider Report for VACCINEX, INC. (VCNX)

Role
Chief Operating Officer
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Elizabeth Evans
Stock symbol
VCNX
Transactions as of
May 11, 2021
Transactions value $
$0
Form type
3
Date filed
5/21/2021, 05:03 PM
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 9.6K May 11, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VCNX Stock Option (Right to Buy) May 11, 2021 Common Stock 9.61K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) May 11, 2021 Common Stock 8.61K $7.10 Direct F1
holding VCNX Stock Option (Right to Buy) May 11, 2021 Common Stock 12.4K $3.90 Direct F2
holding VCNX Stock Option (Right to Buy) May 11, 2021 Common Stock 10K $3.82 Direct F3
holding VCNX Stock Option (Right to Buy) May 11, 2021 Common Stock 8K $2.93 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully exercisable as of the date of this report
F2 This option has vested with respect to 6,200 shares and the remainder vests in two equal annual installments beginning on March 15, 2022.
F3 This option has vested with respect to 2,500 shares and the remainder vests in three equal annual installments beginning on April 3, 2022.
F4 This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.